Zurich, Switzerland

Lukas Langenegger

This inventor holds 1 USPTO granted patent. Top assignee: Hemotune Ag. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lukas Langenegger. Retrieved from https://idiyas.com/inventor/lukas-langenegger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Lukas Langenegger in Extracorporeal Treatment

Introduction

Lukas Langenegger is an innovative inventor based in Zürich, Switzerland. He has made significant contributions to the field of medical technology, particularly in the treatment of sepsis. His work focuses on developing methods that enhance the efficacy of extracorporeal treatment of body fluids.

Latest Patents

Langenegger holds a patent for an "Assembly for extracorporeal treatment of body fluids." This invention outlines a method for treating a patient's body fluid suffering from sepsis. The process involves removing harmful substances from the body fluid through a series of steps, including the injection of a mixture containing functionalized magnetic particles. These particles are designed to target specific molecules in the body fluid, thereby reducing their concentration effectively.

Career Highlights

Lukas Langenegger is associated with Hemotune AG, a company dedicated to advancing medical technologies. His work at Hemotune AG has been pivotal in developing innovative solutions for critical health issues. Langenegger's patent reflects his commitment to improving patient outcomes through scientific advancements.

Collaborations

Langenegger collaborates with notable professionals in his field, including Carlos Mora and Jean-Claude Metzger. These partnerships enhance the research and development efforts at Hemotune AG, fostering an environment of innovation and collaboration.

Conclusion

Lukas Langenegger's contributions to the field of extracorporeal treatment demonstrate his dedication to medical innovation. His patent and work at Hemotune AG highlight the importance of addressing critical health challenges through advanced technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…